These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7239174)

  • 1. Bromocriptine, dihydroergotoxine and sleep in rats: effects of repeated administration.
    Radulovacki M; Brodie M; Walovitch R; Yanik G
    Gerontology; 1981; 27(3):152-7. PubMed ID: 7239174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated administrations of dihydroergotoxine (Redergine) on the sleep-wakefulness cycle in the cat.
    Susić V; Masirević G
    Gerontology; 1981; 27(1-2):1-6. PubMed ID: 7215813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dihydroergotoxine methane sulphonate (Redergine) on sleep in cats deprived of paradoxical sleep.
    Susić V; Ponomarev D; Bosković J; Masirević G
    Arch Int Physiol Biochim; 1981 Dec; 89(5):411-5. PubMed ID: 6176197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
    Vigouret JM; Bürki HR; Jaton AL; Züger PE; Loew DM
    Pharmacology; 1978; 16 Suppl 1():156-73. PubMed ID: 565520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat.
    Monti JM; Hawkins M; Jantos H; D'Angelo L; Fernández M
    Psychopharmacology (Berl); 1988; 95(3):395-400. PubMed ID: 3137628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenoxybenzamine and bromocriptine attenuate need for REM sleep in rats.
    Radulovacki M; Wojcik WJ; Walovitch R; Brodie M
    Pharmacol Biochem Behav; 1981 Mar; 14(3):371-5. PubMed ID: 7232462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dihydroergotoxine, bromocriptine, and ergotamine on penile erection in Wistar rats.
    Radosavljevic M; Pajovic B; Radunovic M; Radojevic N; Bjelogrlic B
    J Androl; 2012; 33(5):866-71. PubMed ID: 22441761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the rat electrocorticogram following administration of two dihydrogenated ergot derivatives.
    Carruthers-Jones DI; Depoortere H; Loew DM
    Gerontology; 1978; 24 Suppl 1():23-33. PubMed ID: 412729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dihydroergotoxine (Redergine) on the sleep-wakefulness cycle in the cat.
    Susić V; Masirević G
    Gerontology; 1979; 25(4):212-8. PubMed ID: 222649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the rat.
    Scheller D; Dürmüller N; Moser P; Porsolt RD
    Eur J Pharmacol; 2008 Apr; 584(1):111-7. PubMed ID: 18304531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep and local field potential effect of the D2 receptor agonist bromocriptine during the estrus cycle and postpartum period in female rats.
    Tóth A; Keserű D; Pethő M; Détári L; Bencsik N; Dobolyi Á; Hajnik T
    Pharmacol Biochem Behav; 2024 Jun; 239():173754. PubMed ID: 38537873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive allosteric modulation of mGlu7 receptors by AMN082 affects sleep and wakefulness in the rat.
    Cavas M; Scesa G; Navarro JF
    Pharmacol Biochem Behav; 2013 Feb; 103(4):756-63. PubMed ID: 23262401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation.
    Lima MM; Andersen ML; Reksidler AB; Silva A; Zager A; Zanata SM; Vital MA; Tufik S
    Behav Brain Res; 2008 Apr; 188(2):406-11. PubMed ID: 18201777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong rebound of wakefulness follows prostaglandin D2- or adenosine A2a receptor agonist-induced sleep.
    Gerashchenko D; Okano Y; Urade Y; Inoué S; Hayaishi O
    J Sleep Res; 2000 Mar; 9(1):81-7. PubMed ID: 10733693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dihydrogenated ergot alkaloids on the sleep-wakefulness cycle and on brain biogenic amines in the rat.
    Loew DM; Depoortere H; Buerki HR
    Arzneimittelforschung; 1976; 26(6):1080-3. PubMed ID: 822856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ergot and non-ergot serotonin antagonists by prolactin and growth hormone profiles during wakefulness and sleep.
    Clarenbach P; Del Pozo E; Brownell J; Heredia E; Spiegel R; Cramer H
    Brain Res; 1980 Dec; 202(2):357-63. PubMed ID: 7437907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oxcarbazepine on sleep architecture.
    Ayala-Guerrero F; Mexicano G; González V; Hernandez M
    Epilepsy Behav; 2009 Jul; 15(3):287-90. PubMed ID: 19379835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of partial and generalised epileptic seizures on sleep architecture in rats].
    López-Ruiz E; Vega-Flores G; Contreras-Cisneros B; Martínez A; Rivera-García AP
    Rev Neurol; 2015 Apr; 60(7):289-95. PubMed ID: 25806477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.